Varma, Prerna
Shen, Lin
Postnova, Svetlana
King, Kylie
Howard, Mark E.
Aidman, Eugene
Rajaratnam, Shantha W. M.
Sletten, Tracey L.
Funding for this research was provided by:
Defence Science and Technology Group
Article History
Received: 17 June 2024
Accepted: 7 March 2025
First Online: 26 March 2025
Declarations
:
: Drs Varma, Shen and King, A/Prof Sletten and Prof Aidman have no conflicts of interest to declare in relation to this study. Other authors note following disclosures: Dr Postnova has no conflict of interest to declare. In the interest of full disclosure, she has projects with Qantas Airways Ltd and has an unpaid appointment with the Sleep Health Foundation. A/Prof Howard reports receiving institutional consulting fees from Teva Pharmaceuticals, Biogen, and Sanofi; and equipment to support research from Optalert and Philips Respironics outside the submitted work. Prof Rajaratnam is the current chair of the Sleep Health Foundation and has also been supported on grants from Vanda Pharmaceuticals, Philips Respironics, Cephalon, Rio Tinto, BHP Billiton, and Shell. Prof Rajaratnam also has received other support from Optalert, Compumedics, Teva Pharmaceuticals and Circadian Therapeutics, through his institution. He is a member of the National Sleep Foundation Sleep Timing Variability Consensus Panel, for which he was paid an honorarium through his institution. None of these disclosures are related to the current study.